Cue Health Inc. (HLTHQ)
Market Cap | 917.26K |
Revenue (ttm) | 70.94M |
Net Income (ttm) | -373.46M |
Shares Out | 152.88M |
EPS (ttm) | -2.44 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 912,197 |
Open | 0.0056 |
Previous Close | 0.0055 |
Day's Range | 0.0055 - 0.0100 |
52-Week Range | 0.0036 - 0.0175 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | n/a |
About HLTHQ
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, C... [Read more]
Financial Performance
In 2023, Cue Health's revenue was $70.94 million, a decrease of -85.33% compared to the previous year's $483.48 million. Losses were -$373.46 million, 92.5% more than in 2022.
Financial numbers in USD Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/n/e/press16-2450632.jpg)
Cue Health to Pursue Wind Down of the Business
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U...
![](https://cdn.snapi.dev/images/v1/x/k/press9-2428487.jpg)
Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the “Company”), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-1...
![](https://cdn.snapi.dev/images/v1/j/j/conf15-2398243.jpg)
Cue Health to Announce First Quarter Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 20...
![](https://cdn.snapi.dev/images/v1/d/o/press16-2334202.jpg)
Cue Health Announces Strategic Actions to Position Company for Next Stage
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the “Boar...
![](https://cdn.snapi.dev/images/v1/4/f/press14-2323079.jpg)
Cue Health Reports Fourth Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. Recent...
![](https://cdn.snapi.dev/images/v1/i/a/conf2-2299577.jpg)
Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wed...
![](https://cdn.snapi.dev/images/v1/t/m/press12-2281170.jpg)
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced it entered into a cooperation agreement (the “Cooperation Agreement”) with Tarsadia Investments ...
![](https://cdn.snapi.dev/images/v1/0/f/press11-2254096.jpg)
Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the BTIG MedTech, Digital Health, Life Scie...
![](https://cdn.snapi.dev/images/v1/i/v/press12-2147996.jpg)
Cue Health Reports Third Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter 2023. Recent Highlights Reported third quart...
![](https://cdn.snapi.dev/images/v1/u/a/conf17-2120907.jpg)
Cue Health to Announce Third Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2023 financial results on Wednesday, Novembe...
![](https://cdn.snapi.dev/images/v1/3/m/press15-2094068.jpg)
Concerned Stockholders of Cue Health Send Letter to Board
LOS ANGELES--(BUSINESS WIRE)--Kelly Day and other concerned stockholders sent a letter to the board of directors of Cue Health outlining their urgent concerns for the Company.
![](https://cdn.snapi.dev/images/v1/n/q/press18-2089519.jpg)
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health's Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, announced today the peer-reviewed publication of an independent clinical study - the largest of its kind on asym...
![](https://cdn.snapi.dev/images/v1/b/o/press9-2073705.jpg)
Cue Health Adopts Limited-Duration Shareholder Rights Plan
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration sharehol...
![](https://cdn.snapi.dev/images/v1/e/t/press5-2044969.jpg)
Tarsadia Investments Sends Letter to Board of Cue Health, Inc.
NEW YORK--(BUSINESS WIRE)--Tarsadia Investments, LLC (“Tarsadia”) represents long-term stockholders of Cue Health, Inc. (the “Company” or “Cue”) (NASDAQ: HLTH), with holdings that collectively make th...
![](https://cdn.snapi.dev/images/v1/q/d/conf17-2033994.jpg)
Cue Health to Present at Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences: 2023 Wells ...
![](https://cdn.snapi.dev/images/v1/c/7/press16-2015662.jpg)
Cue Health Reports Second Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the second quarter 2023. Recent Highlights Reported second qua...
![](https://cdn.snapi.dev/images/v1/z/p/press20-2005891.jpg)
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced Res...
![](https://cdn.snapi.dev/images/v1/3/n/conf5-1990201.jpg)
Cue Health to Announce Second Quarter 2023 Financial Results
SAN DIEGO, Calif.--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2023 financial results on Wednesday...
![](https://cdn.snapi.dev/images/v1/q/u/press10-1923609.jpg)
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and ...
![](https://cdn.snapi.dev/images/v1/g/i/ikiglhe665ptdfewjtrjw5tlqq-1923587.jpg)
US FDA approves Cue Health's at-home COVID test
The U.S. Food and Drug Administration on Tuesday approved Cue Health's at-home COVID-19 test, the first coronavirus test to get marketing authorization using a traditional premarket review, the agency...
![](https://cdn.snapi.dev/images/v1/0/n/conf20-1915165.jpg)
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
SAN DIEGO, Calif.--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Goldman Sachs 44th Annual Global He...
![](https://cdn.snapi.dev/images/v1/y/r/press10-1883526.jpg)
Cue Health Reports First Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the first quarter 2023. Recent Highlights Reported first quart...
![](https://cdn.snapi.dev/images/v1/2/8/press16-1879575.jpg)
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for...
![](https://cdn.snapi.dev/images/v1/w/b/press7-1877032.jpg)
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with...
![](https://cdn.snapi.dev/images/v1/l/2/conf17-1856025.jpg)
Cue Health to Announce First Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10,...